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(5.1%2.7%) compared with control group (6.7%3.2%) (P <0.01 VS P¼0.04) at 10
mins after tiroﬁban infusion. The PMPs were also lower in intracoronary group than
intravenous group (P¼0.02). At 24 hours after tiroﬁban infusion, the PMPs of
intracoronary and intravenous group was similar (P>0.05) and was signiﬁcantly
higher than control group (P¼0.01 VS P ¼0.03) .PMPs was similar at 12 after
stopping tiroﬁban use among the 3 groups (P>0.05) .Intracoronary group were su-
perior to intravenous group and control group in terms of TIMI ﬂow grade (P¼0.03
VS P<0.01) and TIMI myocardial perfusion grade (P¼0.02 VS P<0.01) immediately
after PCI. MACEs rate in intracoronary group was lower than control group (P¼0.03) .And
MACEs rate between intracoronary group and intravenous group, intravenous group
and control group were similar (P>0.05, respectivly). The incidence of bleeding
events among 3 groups was similar.
Conclusions: Intracoronary tiroﬁban compared to the intravenous group, can effec-
tively reduce the number of PMPs in patients with acute ST-segment elevation
myocardial infarction undergoing emergency interventional treatment, achieve the
purpose of the inhibition of activated platelets quickly, and reduce total MACEs
events rate, but did not increase the risk of bleeding.
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Objectives: TNF receptor-associated factor 6 (TRAF6) acts as a multifunctional
regulator of the transforming growth factor (TGF) -b signaling pathway, and mediates
Smad-independent JNK and p38 activation via TGF-b. This study was performed to
test the hypothesis that TGF-b/TRAF6 is essential for angiotensin-II (Ang II) -induced
differentiation of rat c-kit+ cardiac stem cells (CSCs) .
Methods: c-kit+ CSCs were isolated from neonatal Sprague Dawley (SD) rats, and
their c-kit status was conﬁrmed with immunoﬂuorescence staining. A TGF-b type I
receptor inhibitor (SB431542) or the small interfering RNA (siRNA) -mediated
knockdown of TRAF6 were used to investigate the role of TRAF6 in TGF-b
signaling. Rescue of TRAF6 siRNA transfected cells with a 3’UTR deleted siRNA
insensitive construct was conducted to rule out the off target effects of the siRNA.
TRAF6 dominant negative (TRAF6DN) vector was constructed and used to infect c-
kit+ CSCs, and western blotting was used to assess the expression of TRAF6, JNK,
p38, cardiac-speciﬁc proteins, and Wnt signaling proteins. Physical interactions be-
tween TRAF6 and TGFb receptors were studied by coimmunoprecipitation.
Results: Cardiac differentiation was suppressed in the absence of TRAF6. Forced
expression of TRAF6 enhanced the expression of TGF-b-activated kinase1 (TAK1),
and inhibited Wnt signaling. Furthermore, TRAF6 increased the expression of car-
diac-speciﬁc proteins (cTnT and Cx-43) but inhibited the expression of Wnt3a.
Conclusions: Our data suggest that TRAF6 plays an important role in Ang II induced
differentiation of c-kit+ CSCs via the non-canonical signaling pathway.
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Objectives: Herbal medicine, also known as Chinese medicine, plays a role in
treatment of heart failure. Aconite, as one of Chinese medicine, is useful for treatment
of heart failure. purpose of this study is to test efﬁcacy of aconite compound in
improving heart funciton from both clinical and animal study to provide reference for
clinical application.
Methods: (1) Clinical study 41 Patients with chronic heart failure (CHF) were given
treatment of Chinese medicine aconite compound (twice daily for 8 weeks). Before
and after treatment, cardiac function (according to New York Heart Association
NYHA classiﬁcation method) and echocardiography (LVEF%) were observed; (2)
Animal study SD rats (SPF, male, 240 - 280g), acute heart failure model was used as
follows (isolated right carotid artery, heparin catheter was inserted through aortic
valve into left ventricular cavity, intravenous injection of nimodipine (0.6 mg/kg),
when left ventricular pressure maximal rate of rise (+LVdp/dtmax) decreased signif-
icantly, given treatment drugs, (Aconite compound dose as 7g/kg and duodenal
administration, and Cedilanid 0.2mg/kg, femoral vein injection), continue tracings 1h,
including before modeling, modeling immediately, after administration 10 mins, 20
mins, 30 mins, 40 mins, 50 mins, 60 mins to observe following indicators: left ven-
tricular systolic pressure (LVSP mmHg), left ventricular end-diastolic pressure
(LVEDP mmHg) .
Results: (1) 21 patients were male (44.9%), 20 patients were female (55.1%), mini-
mum age is 53 years, the maximum age is 95 years, mean age 73.88 +1.343 (years old),
P¼0.24>0.05, normal distribution; there was improvement of heart function acording
to before and after treatment echocardiography, the LVEF% Value was as follows:
44.71 +14.846 % VS 52.05 +14.854 %, t¼-2.669, P¼0.014<0.05; (2) Compared with
normal group, LVEDP (-0.290.57 vs 1.960.99, P<0.05) were signiﬁcantly higher,
LVSP (105.376.39 VS 129.007.47, P <0.01) was signiﬁcantly lower for acuteC58 JACC Vol 64/16/Suppl C j Octobheart failure group. After femoral vein injection cedilanid 0.2mg/kg, compared with
the model group, LVEDP decreased signiﬁcantly (-0.741.12 VS -0.531.18), LVSP
signiﬁcantly higher (107.737.49 VS 117.117.16 ) after the treatment at 10mins,
118.007.45 at 20 mins, 118.647.44 at 30mins, 120.058.25 at 40mins,
122.748.80 at 50 mins, 125.049.71 at 60mins), heart failure model copied suc-
cessfully; Aconite compound 7g/kg were administered orally to acute heart failure
rats, LVSP (105.376.39 in model group vs 112.365.83 at 10 mins, 115.696.29 at
20mins, 117.217.71 at 30mins, 118.3410.99at 40mins, 120.08 12.82 at 50mins,
123.9611.95 at 60mins), LVEDP (1.960.99 VS 0.050.87 at 10mins, -0.00 0.99
at 20 mins, -0.06 0.85 at 30mins, 0.02 0.84 at 40mins, 0.140.87at 50mins,
0.130.77 at 60 mins after the treatment) showed signiﬁcant improvement
(P<0.05;P<0.01).
Conclusions: Aconite compound can be used for the heart failure by improving hear
function, and there is no signiﬁcant side effects if it is used properly.
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Objectives: Currently, cardiosphere (CSP) and cardiosphere-derived cells (CDCs) are
mainly obtained through myocardial biopsy and surgical, but there is limited access to
tissue size, technical requirements and faced with infection, trauma and other prob-
lems. We assume that there is still a large number cardiac stem cell survival in the
cadaver cardiac, we can get a sufﬁcient amount of functional CSPs and CDCs through
cadaver autopsy methods.
Methods: Mouse (C57BL/6) were sacriﬁced and placed in a refrigerator at 4 C for
0 to 3 days, cardiac tissue was removed at different time points (D0, D1, D2, D3), cut
into small pieces (approximately 1.5 cm3) and placed into dishes to culture explant-
derived cells (EDCs) with complete explant medium. Flow cytometry analysis the
expression of stem cell surface markers of EDCs such as CD117, CD133, CD105,
Sca-1, CD90. EDCs were cultured with Cardiosphere growth medium to form CSP.
CD105, CD117, GATA-4, Nkx2.5 and Connexin-43 were detected by immunoﬂuo-
rescence. CSP was placed in ﬁbronectin covered ﬂasks and grow into a layer of CDCs.
Early cardiac transcription factors GATA-4, Nkx2.5 and Connexin-43 were detected
by polymerase chain reaction (PCR), cardiac stem cell surface markers CD117 and
Sca-1 were tested by ﬂow cytometry. The proliferation ability was tested by cck-8, c-
TnI and vWF were stained by immunoﬂuorescence after induction of differentiation.
Results: Nine days after placing the cardiac tissue in dishes, EDCs from mouse
cadaver cardiac were successfully isolated and cultured. Each group of EDCs are rich
in stem cell surface markers expressing such as CD117, CD133, CD105, Sca-1,
CD90, and could culture into CSP and CDCs. With the extension of the dead days, the
number of EDCs was able to harvest from the autopsy gradually decreased, the
amount of EDCs could harvest at D3 decreased signiﬁcantly (the number of each 60
mm dishes at D0, D1, D2, D3 were 86.005.27104, 66.923.15104,
49.673.17104, 23.751.52104, respectively). There is no signiﬁcant differences
in CD117 and Sca-1 expression at D0 and D1 in EDCs and CDCs, but decreased at D2
and D3. No signiﬁcant difference was found in the ability of EDCs to form CSPs (the
number of each well of 24-well plate at D0, D1, D2, D3 were 38.331.25,
38.002.45, 37.331.25, 38.002.16, respectively), and each group of CSPs was
positive expression CD117, CD105, GATA-4, NKX2.5 and Connexin-43. CDCs
obtained from cadaver autopsy both express GATA-4, Nkx2.5 and Connexin-43 when
detected by PCR and immunoﬂuorescence, but decreased in D2 and D3. There is no
signiﬁcant difference in proliferation when detect by cck-8 and c-TnI, vWF expression
after induction of CDCs.
Conclusions: There is a variety of stem cells survival in cadaveric cardiac even at three
days post-mortem. EDCs harvested through cadaver autopsy methods can form enough
CSPs and CDCs. CDCs from cadaver autopsy also have strong ability of proliferation
and differentiation. CSPs and CDCs obtained from cadaver autopsy may be used as a
source or alternative sources of allograft transplantation and needs further research in
vivo, which may solve the insufﬁcient source problems existing in cardiac stem cells.
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Objectives: Unstable angina (UA), an acute coronary syndrome caused by disruption
of atherosclerotic plaque triggered thrombosis. The blood vessel narrow and reduction
of blood ﬂow induce the symptom. Statin therapy beneﬁts UA patients by cholesterol
independent effect. Yet the mechanism of statin pleiotropic effect remained to be
study. MicroRNAs (miRNAs), small non-coding RNAs, are post-transcriptional
regulators of gene expression. In this study we aim to investigate statins’ novel
mechanism mediated by miRNAs. Moreover we carry out systematic analysis of the
miRNAs functional networks in atherosclerotic lesions.er 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
